Beacon Biosignals Integrates CleveMed, SleepView Under Unified Brand
The consolidation brings together CleveMed’s home sleep testing infrastructure and Beacon’s AI-driven brain monitoring technology to advance at-home sleep diagnostics.
The consolidation brings together CleveMed’s home sleep testing infrastructure and Beacon’s AI-driven brain monitoring technology to advance at-home sleep diagnostics.
The identification of 'social apnea' suggests testing protocols may miss peak disease burden—and misclassify risk.
CPAP data is readily available. Increasingly, so are metrics from other therapy modalities. So why are some clinicians positing that therapeutic device-supplied numbers aren’t enough?
A new study finds strong agreement between the Onera Sleep Test System and traditional polysomnography for AHI and other key respiratory metrics.
Read MoreSleep Review’s guide compares options on parameters including form factor, wavelengths, sampling rates, optical architecture, and more.
Read MoreThe clearance means Huxley Medical’s SANSA can systematically detect cardiac arrhythmias, aiming to restore a key function of in-lab polysomnography.
Read MoreThe SANSA test can now differentiate central from obstructive sleep apnea.
Read MoreThis guide compares sleep study belts on features such as dimensions, disposable versus reusable, patient range, and technology.
Read MoreHow many nights? How to interpret so much data? Which AHI is ‘real’?
Read MoreIt’s also future-ready—designed with the proposed HST CPT codes in mind.
Read More‘Our collaboration with home sleep testing specialists highlights how convenient and accurate identification of sleep disorders can accelerate mental health recovery.’
Read More‘We can instill physician confidence in new home sleep testing modalities that provide accurate diagnostic data in simple, affordable form factors to replace aging legacy devices.’
Read MoreWhen a patient, surprisingly, does not meet Inspire thresholds during in-lab PSG, a home sleep test rescues the case.
Read MoreAn observational study of a 67-year-old man evaluated the feasibility of a home sleep test to simultaneously assess sleep apnea, arrhythmia, and activity patterns for 24 hours.
Read MoreA new code set is on track for January 2027. Also, three HST codes are marked for deletion.
Read MoreThe partnership provides an avenue to reach more patients, no matter their location or ability to visit traditional sleep labs.
Read MoreResmed has completed scaling up the availability of NightOwl, its FDA-cleared fingertip home sleep test acquired from Ectosense, now making the simplified, disposable OSA diagnostic device broadly accessible across the US market.
Read MoreEnsoData enhances its FDA-cleared EnsoSleep PPG home sleep testing solution by adding three new physiological data channels.
Read More